Hui Jiang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Epidemiology top 2%
- Autophagy in Disease and Therapy
Papers in
-
- RNA modifications and cancer 11
- Circular RNAs in diseases 10
- Gut microbiota and health 5
- RNA Research and Splicing 5
-
- Cancer-related molecular mechanisms research 28
- MicroRNA in disease regulation 6
- Co-authors
- Beth Levine (3 shared papers)Xiao Liang (1 shared paper)Brian Herman (1 shared paper)James E. Goldman (1 shared paper)Gerald W. Gordon (1 shared paper)Fan Chang (15 shared papers)Jian Liu (16 shared papers)Jiarong Gao (18 shared papers)
- Journals
- Gene (5 papers)Journal of Ethnopharmacology (5 papers)International Journal of Molecular Medicine (4 papers)Journal of Virology (4 papers)BMC Genomics (3 papers)
- Partner nations
- ChinaUnited StatesEstonia
In The Last Decade
Hui Jiang
139 papers receiving 2.8k citations
Hui Jiang's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 524
- Epidemiology 930
- Physiology 89
- Molecular Biology 1.2k
- Cell Biology 220
Countries citing papers authored by Hui Jiang
This map shows the geographic impact of Hui Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Jiang more than expected).
Fields of papers citing papers by Hui Jiang
This network shows the impact of papers produced by Hui Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Jiang. The network helps show where Hui Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Protection against Fatal Sindbis Virus Encephalitis by Beclin, a Novel Bcl-2-Interacting Protein Hit paper breakdown → | 1998 | 952 |
| 2 | 2022 | 90 | |
| 3 | 2017 | 82 | |
| 4 | 2020 | 61 | |
| 5 | 2006 | 53 | |
| 6 | 2020 | 50 | |
| 7 | 2019 | 50 | |
| 8 | 2021 | 45 | |
| 9 | 2021 | 45 | |
| 10 | 2021 | 37 | |
| 11 | 1996 | 32 | |
| 12 | 2018 | 31 | |
| 13 | 2018 | 30 | |
| 14 | 2021 | 30 | |
| 15 | 2022 | 29 | |
| 16 | 2006 | 29 | |
| 17 | 2016 | 27 | |
| 18 | 2016 | 27 | |
| 19 | 2020 | 24 | |
| 20 | 2021 | 23 |
About Hui Jiang
Hui Jiang is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Rheumatology and Surgery, having authored 148 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (28 papers), RNA modifications and cancer (11 papers), Circular RNAs in diseases (10 papers), Liver Disease Diagnosis and Treatment (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers), MicroRNA in disease regulation (6 papers), Gut microbiota and health (5 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (524 citations), Epidemiology (930 citations), Physiology (89 citations), Molecular Biology (1.2k citations) and Cell Biology (220 citations). Hui Jiang has collaborated with scholars based in China, United States and Estonia. Frequent co-authors include Beth Levine, Xiao Liang, Brian Herman, James E. Goldman, Gerald W. Gordon, Fan Chang, Jian Liu, Jiarong Gao, Xiujuan Qin and Weiping Li. Their work appears in journals such as Gene, Journal of Ethnopharmacology, International Journal of Molecular Medicine, Journal of Virology and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.